{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:37:17Z","timestamp":1776868637801,"version":"3.51.2"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008771","name":"Animal and Plant Quarantine Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.antiviral.2017.04.009","type":"journal-article","created":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T18:03:19Z","timestamp":1493143399000},"page":"195-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Coinjection of a vaccine and anti-viral agents can provide fast-acting protection from foot-and-mouth disease"],"prefix":"10.1016","volume":"143","author":[{"given":"Su-Hwa","family":"You","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taeseong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo-Hyung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gundo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang-Nyeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byounghan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myoung-Heon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Mi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Hyeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2017.04.009_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9975(03)00041-0","article-title":"The pathogenesis and diagnosis of foot-and-mouth disease","volume":"129","author":"Alexandersen","year":"2003","journal-title":"J.\u00a0Comp. Pathol."},{"key":"10.1016\/j.antiviral.2017.04.009_bib2","first-page":"9","article-title":"Foot-and-mouth disease: host range and pathogenesis","volume":"288","author":"Alexandersen","year":"2005","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2017.04.009_bib3","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1128\/AAC.00208-15","article-title":"Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection","volume":"59","author":"Berhanu","year":"2015","journal-title":"Antimicrob. agents Chemother."},{"key":"10.1016\/j.antiviral.2017.04.009_bib4","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1016\/j.vaccine.2013.07.008","article-title":"Delivery of synthetic RNA can enhance the immunogenicity of vaccines against foot-and-mouth disease virus (FMDV) in mice","volume":"31","author":"Borrego","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.04.009_bib5","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1128\/JVI.78.13.6900-6907.2004","article-title":"RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice","volume":"78","author":"Chen","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.04.009_bib6","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1128\/JVI.77.2.1621-1625.2003","article-title":"Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease","volume":"77","author":"Chinsangaram","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.04.009_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1051\/vetres:2008051","article-title":"Experimental evaluation of foot-and-mouth disease vaccines for emergency use in ruminants and pigs: a review","volume":"40","author":"Cox","year":"2009","journal-title":"Veterinary Res."},{"key":"10.1016\/j.antiviral.2017.04.009_bib8","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1016\/j.vaccine.2006.02.011","article-title":"Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha","volume":"24","author":"de Avila Botton","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.04.009_bib9","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1128\/JVI.01874-09","article-title":"Interferon-induced protection against foot-and-mouth disease virus infection correlates with enhanced tissue-specific innate immune cell infiltration and interferon-stimulated gene expression","volume":"84","author":"Diaz-San Segundo","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.04.009_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0168-1702(02)00261-7","article-title":"FMD vaccines","volume":"91","author":"Doel","year":"2003","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2017.04.009_bib11","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1016\/j.vaccine.2005.07.043","article-title":"Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: use in emergency outbreak response","volume":"23","author":"Golde","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.04.009_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.antiviral.2006.09.007","article-title":"2'-C-methylcytidine as a potent and selective inhibitor of the replication of foot-and-mouth disease virus","volume":"73","author":"Goris","year":"2007","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.04.009_bib13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.17.2.465-493.2004","article-title":"Foot-and-mouth disease","volume":"17","author":"Grubman","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2017.04.009_bib14","first-page":"227","article-title":"Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals","volume":"33","author":"Grubman","year":"2005","journal-title":"Biol. J. Int. Assoc. Biol. Stand."},{"key":"10.1016\/j.antiviral.2017.04.009_bib15","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1099\/vir.0.068270-0","article-title":"Laboratory animal models to study foot-and-mouth disease: a review with emphasis on natural and vaccine-induced immunity","volume":"95","author":"Habiela","year":"2014","journal-title":"J.\u00a0general Virol."},{"key":"10.1016\/j.antiviral.2017.04.009_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ejmech.2015.08.020","article-title":"Synthesis and in-vitro evaluation of 2-amino-4-arylthiazole as inhibitor of 3D polymerase against foot-and-mouth disease (FMD)","volume":"102","author":"Jeong","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.antiviral.2017.04.009_bib17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.antiviral.2008.06.001","article-title":"Therapeutic application of RNA interference against foot-and-mouth disease virus in\u00a0vitro and in\u00a0vivo","volume":"80","author":"Kim","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.04.009_bib18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.antiviral.2010.06.004","article-title":"Multiple shRNAs driven by U6 and CMV promoter enhances efficiency of antiviral effects against foot-and-mouth disease virus","volume":"87","author":"Kim","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.04.009_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.antiviral.2014.01.014","article-title":"A\u00a0recombinant adenovirus bicistronically expressing porcine interferon-alpha and interferon-gamma enhances antiviral effects against foot-and-mouth disease virus","volume":"104","author":"Kim","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.04.009_bib20","doi-asserted-by":"crossref","first-page":"8267","DOI":"10.1128\/JVI.00766-15","article-title":"Robust protection against highly virulent foot-and-mouth disease virus in swine by combination treatment with recombinant adenoviruses expressing porcine alpha and gamma interferons and multiple small interfering RNAs","volume":"89","author":"Kim","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.04.009_bib21","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1128\/JCM.03220-14","article-title":"Correction for LaRocco et\u00a0al., A Continuous Bovine Kidney Cell Line Constitutively Expressing Bovine alphaVbeta6 Integrin Has Increased Susceptibility to Foot-and-Mouth Disease Virus","volume":"53","author":"LaRocco","year":"2015","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2017.04.009_bib22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fvets.2016.00102","article-title":"Challenges of generating and maintaining protective vaccine-induced immune responses for foot-and-mouth disease virus in pigs","volume":"3","author":"Lyons","year":"2016","journal-title":"Front. veterinary Sci."},{"key":"10.1016\/j.antiviral.2017.04.009_bib23","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/eji.200535537","article-title":"A\u00a0Trypanosoma cruzi antigen signals CD11b+ cells to secrete cytokines that promote polyclonal B cell proliferation and differentiation into antibody-secreting cells","volume":"36","author":"Montes","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.antiviral.2017.04.009_bib24","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1128\/JVI.02775-06","article-title":"Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons","volume":"81","author":"Moraes","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.04.009_bib25","doi-asserted-by":"crossref","first-page":"9357","DOI":"10.1128\/JVI.00677-07","article-title":"The early protective thymus-independent antibody response to foot-and-mouth disease virus is mediated by splenic CD9+ B lymphocytes","volume":"81","author":"Ostrowski","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.04.009_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.virol.2005.04.014","article-title":"Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine","volume":"337","author":"Pacheco","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2017.04.009_bib27","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1016\/j.vaccine.2007.08.058","article-title":"Reduction of foot-and-mouth disease (FMD) virus load in nasal excretions, saliva and exhaled air of vaccinated pigs following direct contact challenge","volume":"25","author":"Parida","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.04.009_bib28","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.vaccine.2014.01.067","article-title":"Protection to homologous and heterologous challenge in pigs immunized with vaccine against foot-and-mouth disease type O caused an epidemic in East Asia during 2010\/2011","volume":"32","author":"Park","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.04.009_bib29","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1016\/j.vaccine.2014.07.040","article-title":"Enhanced immune responses of foot-and-mouth disease vaccine using new oil\/gel adjuvant mixtures in pigs and goats","volume":"32","author":"Park","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.04.009_bib30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.trivac.2016.04.006","article-title":"Altered adjuvant of foot-and-mouth disease vaccine improves immune response and protection from virus challenge","volume":"5","author":"Park","year":"2016","journal-title":"Trials Vaccinol."},{"key":"10.1016\/j.antiviral.2017.04.009_bib31","doi-asserted-by":"crossref","first-page":"e1000658","DOI":"10.1371\/journal.ppat.1000658","article-title":"Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections","volume":"5","author":"Perales","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2017.04.009_bib32","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.antiviral.2011.08.007","article-title":"Role of macrophages in early protective immune responses induced by two vaccines against foot and mouth disease","volume":"92","author":"Quattrocchi","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.04.009_bib33","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.vaccine.2014.02.061","article-title":"Early protection against foot-and-mouth disease virus in cattle using an inactivated vaccine formulated with Montanide ESSAI IMS D 12802 VG PR adjuvant","volume":"32","author":"Quattrocchi","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.04.009_bib34","first-page":"7","article-title":"A\u00a0simple method of estimating fifty percent end points","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.antiviral.2017.04.009_bib35","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40781-015-0042-8","article-title":"Foot-and-mouth disease: overview of motives of disease spread and efficacy of available vaccines","volume":"57","author":"Saeed","year":"2015","journal-title":"J.\u00a0Animal Sci. Technol."},{"key":"10.1016\/j.antiviral.2017.04.009_bib36","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.virol.2004.11.005","article-title":"Foot-and-mouth disease virus (FMDV) causes an acute disease that can be lethal for adult laboratory mice","volume":"332","author":"Salguero","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2017.04.009_bib37","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12916-015-0440-2","article-title":"The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments","volume":"13","author":"Scott","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.antiviral.2017.04.009_bib38","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1016\/j.vaccine.2008.03.089","article-title":"The effects of IL-6 and TNF-alpha as molecular adjuvants on immune responses to FMDV and maturation of dendritic cells by DNA vaccination","volume":"26","author":"Su","year":"2008","journal-title":"Vaccine"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216304211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216304211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T10:50:36Z","timestamp":1535885436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216304211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":38,"alternative-id":["S0166354216304211"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.04.009","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coinjection of a vaccine and anti-viral agents can provide fast-acting protection from foot-and-mouth disease","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}